secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001104659-23-124681
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS receives Nasdaq deficiency notice for market value below $35M minimum
----------------------------------------------------------------------------

- Nasdaq notified SLS on Dec 6, 2023 that MV of common stock was below $35M for 30 consecutive business days.
- Company has 180 calendar days, until June 3, 2024, to regain compliance under Nasdaq Listing Rule 5810(c)(3)(C).
- To regain compliance, market value must be at least $35M for 10 consecutive business days during the period.
- Failure to comply by June 3, 2024 may lead to delisting, subject to appeal to a Nasdaq Hearings Panel.
- SLS stock remains listed on Nasdaq Capital Market under symbol SLS at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465923124681/0001104659-23-124681-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465923124681/tm2332442d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-124681

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer